Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
19S(20R)-EpDPA is an oxylipin and a metabolite of docosahexaenoic acid (DHA; Item No. 90310).1,2 It is formed from DHA by various cytochrome P450 (CYP) isoforms in a stereoselective manner.2 Unlike 19R(20S)-EpDPA (Item No. 28628), 19S(20R)-EpDPA does not prevent calcium-induced increases in the spontaneous beating of isolated neonatal rat cardiomyocytes (NRCMs).3
WARNING This product is not for human or veterinary use.
1. Enzymatic synthesis and chemical inversion provide both enantiomers of bioactive epoxydocosapentaenoic acids. J. Lipid Res. 59(11), 2237-2252 (2018).
2. Stereoselective epoxidation of the last double bond of polyunsaturated fatty acids by human cytochromes P450. J. Lipid Res. 51(5), 1125-1133 (2010).
3. Phospholipase A2 structure/function, mechanism, and signaling. J. Lipid Res. 50(Suppl), S237-S242 (2009).